The inclusion of tumour markers such as CA 19-9 and CEA in the regression model improved the explanatory power, underscoring the role of neoplasia-related inflammation in the systemic response observed in adenocarcinoma. The gene discussed is CEACAM5; the disease is adenocarcinoma.